^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
GENE:

UMODL1 (Uromodulin Like 1)

i
Other names: UMODL1, Uromodulin Like 1, Olfactorin, Uromodulin-Like 1
over3years
Construction of a Novel MYC-Associated ceRNA Regulatory Network to Identify Prognostic Biomarkers in Colon Adenocarcinoma. (PubMed, J Oncol)
The predicted target genes of the LINC00114/miR-216a-5p axis include uromodulin Like 1 (UMODL1) and oncoprotein induced transcript 3 (OIT3), which are closely related to the survival and prognosis of COAD patients. In summary, we constructed a novel ceRNA regulatory network and identified potential biomarkers for the targeted therapy and prognosis of COAD.
Journal
|
MYC (V-myc avian myelocytomatosis viral oncogene homolog) • MIR216A (MicroRNA 216a) • UMODL1 (Uromodulin Like 1)
|
MYC expression
over3years
Differential expression and analysis of extrachromosomal circular DNAs as serum biomarkers in lung adenocarcinoma. (PubMed, J Clin Lab Anal)
Our study first showed that several eccDNAs were aberrantly expressed in LAD, among which CircD-PDZRN3 and CircD-LGR6 clearly distinguished LAD patients from healthy controls, indicating their potential as biomarkers.
Journal
|
CEACAM5 (CEA Cell Adhesion Molecule 5) • KRT19 (Keratin 19) • SDK1 (Sidekick Cell Adhesion Molecule 1) • SLC16A3 (Solute Carrier Family 16 Member 3) • UMODL1 (Uromodulin Like 1)
almost4years
Toripalimab Plus Paclitaxel and Carboplatin as Neoadjuvant Therapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma. (PubMed, Oncologist)
The combination of toripalimab plus paclitaxel and carboplatin is safe, feasible, and effective in locally advanced resectable ESCC, indicating its potential as a neoadjuvant treatment for ESCC.
Journal • IO biomarker
|
CD8 (cluster of differentiation 8) • CCL19 (C-C Motif Chemokine Ligand 19) • CXCL5 (Chemokine (C-X-C motif) ligand 5) • UMODL1 (Uromodulin Like 1)
|
carboplatin • paclitaxel • Loqtorzi (toripalimab-tpzi)